Near-infrared Imaging Techniques for Identifying and Preserving Viable Parathyroid Glands During Thyroidectomy
Primary Purpose
Hypoparathyroidism Postprocedural
Status
Recruiting
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Near-infrared-induced autofluorescence and indocyanine green near-infrared angiography
Sponsored by
About this trial
This is an interventional prevention trial for Hypoparathyroidism Postprocedural focused on measuring Near-infrared fluorescence
Eligibility Criteria
Inclusion Criteria:
• Patients 18 years and older who are scheduled to undergo total or completion thyroidectomy at the department of Oro-Rhino-Laryngology (ORL) and Head and Neck Surgery at Odense University Hospital, Denmark.
Exclusion Criteria:
- Not legally competent.
- Does not read or speak Danish.
- Is pregnant or nursing.
- Suffers from chronic kidney disease with an estimated glomerular filtration rate < 45 ml/min/1.73m2.
- Has a history of allergy to iodides or to indocyanine green.
- Suffers from hyperparathyroidism, hypoparathyroidism, or hypocalcaemia prior to surgery.
- Prescription use of supplemental active vitamin D: dihydrotachysterol (ATC 11CC02), alfacalcidol (ATC A11CC03), or calcitriol (ATC A11CC04).
- Patients scheduled to have a radioactive iodine uptake study performed ≤ 7 days after the thyroidectomy.
Sites / Locations
- Odense University HospitalRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
NIRAF+ICGA
Arm Description
During thyroid surgery, near-infrared-induced autofluorescence is used for the identification of the parathyroid glands, combined with indocyanine green near-infrared angiography for identification of the parathyroid feeding vessels.
Outcomes
Primary Outcome Measures
Permanent hypoparathyroidism 12 months after surgery
The number of participants in the study cohort with permanent hypoparathyroidism 12 months after treatment compared to the number of participants with permanent hypoparathyroidism 12 months after treatment in a matched retrospective cohort from the same hospital that underwent surgery without NIRAF+ICGA.
Secondary Outcome Measures
Full Information
NCT ID
NCT05130476
First Posted
November 8, 2021
Last Updated
November 18, 2021
Sponsor
Odense University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT05130476
Brief Title
Near-infrared Imaging Techniques for Identifying and Preserving Viable Parathyroid Glands During Thyroidectomy
Official Title
Intraoperative Near-infrared Imaging Techniques for Identifying and Preserving Viable Parathyroid Glands During Total and Completion Thyroidectomy: a Matched Cohort Study
Study Type
Interventional
2. Study Status
Record Verification Date
November 2021
Overall Recruitment Status
Recruiting
Study Start Date
October 1, 2021 (Actual)
Primary Completion Date
September 30, 2023 (Anticipated)
Study Completion Date
March 31, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Odense University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The parathyroid glands and their blood vessels are notoriously difficult to visualize and may therefore be unintentionally and irrevocably damaged during thyroid surgery. This project investigates new surgeon-performed imaging techniques that visualize the parathyroid glands and their vessels in real-time during thyroid surgery. The purpose is to examine, in a matched cohort study, whether the implementation of near-infrared-induced autofluorescence for identification of the parathyroid glands, combined with indocyanine green near-infrared angiography of the parathyroid feeding vessels, can reduce the incidence of postoperative hypocalcaemia in patients undergoing total and completion thyroidectomy at Odense University Hospital.
Detailed Description
The most common complication after thyroidectomy is postoperative hypoparathyroidism due to unintentional intraoperative injury, excision, or devascularisation of the parathyroid glands. This complication can be either transient (≤6 months), or permanent (> 6 months). The pooled results from four recent studies from three different Danish university hospitals show that 117/945 patients (12.4%) suffered from permanent hypoparathyroidism after total and completion thyroidectomy. This is a very high percentage, considering that the consequences of hypoparathyroidism and its treatment may be severe and include prolonged hospitalization, neuromuscular symptoms, nephrocalcinosis, nephrolithiasis, premature cataracts, seizures, basal ganglia calcification, and increased mortality.
To minimize the risk of postoperative hypoparathyroidism, the standard approach to thyroidectomy is to keep dissection as close to the thyroid capsule as possible while visually scrutinizing the surgical field for the parathyroid glands and their delicate feeding vessels. In spite of these measures, the reported incidences of transient and permanent hypocalcaemia clearly demonstrate a need to further decrease the risk of inadvertent injury to the parathyroid glands and their vessels during thyroid surgery. To achieve this goal, surgeons need a reliable intraoperative aid that can 1) help them identify the parathyroid glands in vivo and 2) locate their feeding vessels and evaluate their perfusion in real-time during thyroid surgery. Recently, two near-infrared fluorescence techniques have emerged, that could potentially meet the requirement of identifying the parathyroid glands and assessing their vasculature using the same piece of technical equipment. The techniques are: near-infrared-induced autofluorescence of the parathyroid glands (NIRAF) for parathyroid identification, and indocyanine green near-infrared angiography (ICGA) for the assessment of parathyroid vascularization. A recent systematic review concluded that these most reported-on optical tools for parathyroid identification and perfusion assessment are favourable for clinical application in terms of being real-time and non-invasive, having a high sensitivity, an excellent safety profile, and involving no exposure to ionizing radiation. Prior to a broader implementation, commercially unaffiliated investigator-initiated studies are needed to evaluate the clinical effect of the bimodal application of NIRAF and ICGA on the incidence of postoperative hypoparathyroidism after total and completion thyroidectomy. This study intends to address this need.
The hypothesis of the study is that near-infrared-induced autofluorescence (NIRAF) combined with indocyanine green near-infrared angiography (ICGA) of the parathyroid glands can reduce the incidence of permanent hypoparathyroidism after total and completion thyroidectomy to 1/3 or less of the incidence in a matched retrospective control group.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypoparathyroidism Postprocedural
Keywords
Near-infrared fluorescence
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Matched cohort study
Masking
None (Open Label)
Allocation
N/A
Enrollment
139 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
NIRAF+ICGA
Arm Type
Experimental
Arm Description
During thyroid surgery, near-infrared-induced autofluorescence is used for the identification of the parathyroid glands, combined with indocyanine green near-infrared angiography for identification of the parathyroid feeding vessels.
Intervention Type
Procedure
Intervention Name(s)
Near-infrared-induced autofluorescence and indocyanine green near-infrared angiography
Intervention Description
During thyroid surgery, near-infrared-induced autofluorescence is used for the identification of the parathyroid glands, combined with indocyanine green near-infrared angiography for identification of the parathyroid feeding vessels.
Primary Outcome Measure Information:
Title
Permanent hypoparathyroidism 12 months after surgery
Description
The number of participants in the study cohort with permanent hypoparathyroidism 12 months after treatment compared to the number of participants with permanent hypoparathyroidism 12 months after treatment in a matched retrospective cohort from the same hospital that underwent surgery without NIRAF+ICGA.
Time Frame
12 months postoperatively
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
• Patients 18 years and older who are scheduled to undergo total or completion thyroidectomy at the department of Oro-Rhino-Laryngology (ORL) and Head and Neck Surgery at Odense University Hospital, Denmark.
Exclusion Criteria:
Not legally competent.
Does not read or speak Danish.
Is pregnant or nursing.
Suffers from chronic kidney disease with an estimated glomerular filtration rate < 45 ml/min/1.73m2.
Has a history of allergy to iodides or to indocyanine green.
Suffers from hyperparathyroidism, hypoparathyroidism, or hypocalcaemia prior to surgery.
Prescription use of supplemental active vitamin D: dihydrotachysterol (ATC 11CC02), alfacalcidol (ATC A11CC03), or calcitriol (ATC A11CC04).
Patients scheduled to have a radioactive iodine uptake study performed ≤ 7 days after the thyroidectomy.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sanne H Michaelsen, MD
Phone
+4565412800
Email
sanne.hoxbroe.michaelsen@rsyd.dk
Facility Information:
Facility Name
Odense University Hospital
City
Odense C
ZIP/Postal Code
5000
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sanne H Michaelsen, MD
Phone
+4565412800
Email
sanne.hoxbroe.michaelsen@rsyd.dk
12. IPD Sharing Statement
Plan to Share IPD
No
Links:
URL
https://open.rsyd.dk/OpenProjects/openProject.jsp?openNo=1434&lang=da
Description
Related Info
Learn more about this trial
Near-infrared Imaging Techniques for Identifying and Preserving Viable Parathyroid Glands During Thyroidectomy
We'll reach out to this number within 24 hrs